XML 95 R85.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Equity - Earnings Per Share ("EPS") (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Basic        
Net income attributable to common stockholders $ 47,397 $ 76,164 $ 105,270 $ 160,483
Net income attributable to common stockholders and noncontrolling interest $ 47,397 $ 76,164 $ 105,270 $ 160,483
Weighted average shares outstanding (in shares) 188,655,801 181,815,469 188,683,095 181,468,002
Weighted average shares outstanding (in shares) 188,655,801 181,815,469 188,683,095 181,468,002
Net income per common share (in dollars per share) $ 0.25 $ 0.42 $ 0.56 $ 0.88
Diluted        
Net income attributable to common stockholders $ 47,397 $ 76,164 $ 105,270 $ 160,483
Net income attributable to noncontrolling interest 4,094 6,826 9,090 14,411
Interest expense on convertible notes 0 6,081 0 12,163
Net income attributable to common stockholders and noncontrolling interest $ 51,491 $ 89,071 $ 114,360 $ 187,057
Weighted average shares outstanding (in shares) 188,655,801 181,815,469 188,683,095 181,468,002
Dilutive effect of OP Units (in shares) 16,293,589 16,293,589 16,293,589 16,293,589
Dilutive effect of convertible notes (in shares) 0 17,270,615 0 17,250,598
Dilutive effect of RSUs (in shares) 538,321 682,203 522,935 477,415
Weighted average shares outstanding ( in shares) 205,487,711 216,061,876 205,499,619 215,489,604
Net income per common share (in dollars per share) $ 0.25 $ 0.41 $ 0.56 $ 0.87
Mr. Ivan Kaufman | Performance-based restricted stock        
Diluted        
Vesting period (in years)     4 years